Low salivary cortisol levels in patients with rheumatoid arthritis exposed to oral glucocorticoids: a cross-sectional study set within UK electronic health records

Joseph, Rebecca M.; Ray, David W.; Keevil, Brian; van Staa, Tjeerd P.; Dixon, William G.

Abstract

Background: Glucocorticoids (GCs) suppress endogenous cortisol levels which can lead to adrenal insufficiency (AI). The frequency of GC-induced AI remains unclear. In this cross-sectional study, low morning salivary cortisol (MSC) levels were used as a measure of adrenal function. The study aim was to investigate the prevalence of low MSC in patients with rheumatoid arthritis (RA) currently and formerly exposed to oral GCs, and the association with potential risk factors.
Methods: Sample collection was nested within UK primary care electronic health records (from the Clinical Practice Research Datalink). Participants were patients with RA with at least one prescription for oral GCs in the past 2 years. Self-reported oral GC use was used to define current use and current dose; prescription data were used to define exposure duration. MSC was determined from saliva samples; 5 nmol/L was the cut-off for low MSC. The prevalence of low MSC was estimated, and logistic regression was used to assess the association with potential risk factors.
Results: 66% of 38 current and 11 % of 38 former GC users had low MSC. Among former users with low MSC, the longest time since GC withdrawal was 6 months. Current GC dose, age and RA duration were significantly associated with increased risk of low MSC.
Conclusion: The prevalence of low MSC among current GC users is high, and MSC levels may remain suppressed for several months after GC withdrawal. Clinicians should therefore consider the risk of suppressed cortisol and remain vigilant for symptoms of AI following GC withdrawal.

Citation

Joseph, R. M., Ray, D. W., Keevil, B., van Staa, T. P., & Dixon, W. G. (2018). Low salivary cortisol levels in patients with rheumatoid arthritis exposed to oral glucocorticoids: a cross-sectional study set within UK electronic health records. RMD Open, 4(2), Article e000700. https://doi.org/10.1136/rmdopen-2018-000700

• Journal Article Type: Article
• Acceptance Date: Jul 18, 2018
• Online Publication Date: Oct 1, 2018
• Publication Date: Oct 1, 2018
• Deposit Date: Dec 18, 2018
• Publicly Available Date: Dec 19, 2018
• Journal: RMD Open
• Electronic ISSN: 2056-5933
• Publisher: BMJ Publishing Group
• Peer Reviewed: Peer Reviewed
• Volume: 4
• Issue: 2
• Article Number: e000700
• DOI: https://doi.org/10.1136/rmdopen-2018-000700
• Public URL: https://nottingham-repository.worktribe.com/output/1421976
• Publisher URL: https://rmdopen.bmj.com/content/4/2/e000700